Home
/
SELLAS Life Sciences Group, Inc.
/
Financials
/
Quarterly
SELLAS Life Sciences Group, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that SELLAS Life Sciences Group, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2023
Sep 30, 2023
$0
Nov 9, 2023
Q2
2023
Jun 30, 2023
$0
Aug 10, 2023
Q1
2023
Mar 31, 2023
$0
May 11, 2023
Q3
2023
Sep 30, 2022
$0
Nov 9, 2023
Q2
2023
Jun 30, 2022
$0
Aug 10, 2023
Q1
2023
Mar 31, 2022
$1.00M
May 11, 2023
Q3
2022
Sep 30, 2021
$0
Nov 14, 2022
Q2
2022
Jun 30, 2021
$1.90M
Aug 11, 2022
Q1
2022
Mar 31, 2021
$5.70M
May 12, 2022
Q3
2021
Sep 30, 2020
$0
Nov 12, 2021
Q2
2021
Jun 30, 2020
$0
Aug 12, 2021
Q1
2021
Mar 31, 2020
$0
May 13, 2021
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2015
Jun 30, 2015
$3.38M
Aug 6, 2015
Q1
2015
Mar 31, 2015
$2.75M
May 7, 2015
Q3
2014
Sep 30, 2014
$1.62M
Nov 5, 2014
Q2
2015
Jun 30, 2014
$2.33M
Aug 6, 2015
Q1
2015
Mar 31, 2014
$2.17M
May 7, 2015
Q3
2014
Sep 30, 2013
$1.17M
Nov 5, 2014
Q2
2014
Jun 30, 2013
$0
Aug 11, 2014
Q1
2014
Mar 31, 2013
$0
May 6, 2014
Q3
2013
Sep 30, 2012
$0
Nov 7, 2013
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($6.79M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($6.60M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($5.81M)
May 13, 2025
Q3
2025
Sep 30, 2024
($7.11M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($7.47M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($9.57M)
May 13, 2025
Q3
2024
Sep 30, 2023
($9.27M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($8.84M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($11.10M)
May 14, 2024
Q3
2023
Sep 30, 2022
($7.02M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($8.41M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($16.74M)
May 11, 2023
Q3
2022
Sep 30, 2021
($7.09M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($4.61M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($2.40M)
May 12, 2022
Q3
2021
Sep 30, 2020
($4.47M)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($4.43M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($4.14M)
May 13, 2021
Q3
2020
Sep 30, 2019
($4.20M)
Nov 13, 2020
Q2
2020
Jun 30, 2019
($3.13M)
Aug 13, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($7.08M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($6.87M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($6.06M)
May 13, 2025
Q3
2025
Sep 30, 2024
($7.33M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($7.62M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($9.65M)
May 13, 2025
Q3
2024
Sep 30, 2023
($9.36M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($9.05M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($11.28M)
May 14, 2024
Q3
2023
Sep 30, 2022
($7.15M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($8.62M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($16.74M)
May 11, 2023
Q3
2022
Sep 30, 2021
($6.98M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($4.45M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($2.25M)
May 12, 2022
Q3
2021
Sep 30, 2020
($4.49M)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($4.27M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($4.06M)
May 13, 2021
Q3
2017
Sep 30, 2017
($4.46M)
Nov 9, 2017
Q2
2017
Jun 30, 2017
($4.91M)
Aug 14, 2017